These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1801431)
1. [The use of obzidan and metoprolol in patients with supraventricular systolic tachyarrhythmias]. Frolov AI; Bobrov VA; Mitchenko EI; Chervonopiskaia EM; Galichanskiĭ IV; Delikatnaia NV Vrach Delo; 1991 Nov; (11):47-50. PubMed ID: 1801431 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of anti-arrhythmic effect of propranolol and metoprolol in patients with supraventricular tachyarrhythmias. Bobrov VA; Frolov AI; Mitchenko YI; Chervonopiskaya YM; Galichansky IV Rev Port Cardiol; 1993; 12(7-8):611-4, 599. PubMed ID: 8352980 [TBL] [Abstract][Full Text] [Related]
3. [Effect of selective and non-selective adrenergic beta receptor blockaders on selected electrophysiologic properties of the human heart]. Ciemniewski Z; Trusz-Gluza M; Swiderska E; Grzegorzewski B; Giec L Kardiol Pol; 1989; 32(6):342-6. PubMed ID: 2561167 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of electrophysiologic effect of metoprolol and disopyramide, acting alone or in combination in patients with supraventricular tachycardia and Wolff-Parkinson-White syndrome. Bobrov VA; Frolov AI; Mitchenko EI; Galichansky IV; Zinchenko YuV Rev Port Cardiol; 1994 Mar; 13(3):221-5. PubMed ID: 8049089 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the activity of the heart conduction system with special reference to the sinoatrial node automatism in patients with mitral valve prolapse syndrome]. Gil R Ann Acad Med Stetin; 1991; 37():87-104. PubMed ID: 1816757 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979 [TBL] [Abstract][Full Text] [Related]
7. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study. Rehnqvist N Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895 [TBL] [Abstract][Full Text] [Related]
11. [Occurrence of latent retrograde atrioventricular conduction reaching the atrial conduction pathways in a patient with paroxysmal tachycardia of the re-entry type within the atrioventricular node after administration of propranolol]. Prochaczek F; Becker A; Matuszewska J Kardiol Pol; 1987; 30(8):495-501. PubMed ID: 3695056 [No Abstract] [Full Text] [Related]
12. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias]. De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800 [TBL] [Abstract][Full Text] [Related]
13. [Supraventricular tachycardia due to simultaneous conduction in the rapid and slow nodal pathways. Treatment by ablation of the slow pathway]. Goutner C; Dechandol AM; Bourguet JC; Donzeau JP Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1651-5. PubMed ID: 8746002 [TBL] [Abstract][Full Text] [Related]
14. [Effect of beta-receptor blocking agent in 2nd degree av-block: conduction study in 9 patients (author's transl)]. Csapo G; Weisswange A; Roskamm H Z Kardiol; 1978 Jun; 67(6):420-7. PubMed ID: 685373 [No Abstract] [Full Text] [Related]
15. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias. Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093 [TBL] [Abstract][Full Text] [Related]
16. [Effect of aminophylline on the heart conduction system in patients with paroxysmal nodal tachycardia]. Molenda W; Telichowski C; Banasiak W; Petruk J Kardiol Pol; 1988; 31(2):84-90. PubMed ID: 3045398 [No Abstract] [Full Text] [Related]
17. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor]. Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of paroxysmal supraventricular tachycardia with a single oral doses of diltiazem and propranolol]. Arnaldo F; García Escudero A; Tajer C; González Zuelgaray J; Bertolasi CA Medicina (B Aires); 1991; 51(1):14-8. PubMed ID: 1921686 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?]. Blagova OV; Nedostup AV Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent. Solti F; Czakó E Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]